Back to Awarded Treatment Trials
Awarded Trial: 05T-656
Grant ID
05T-656
Illness
BP Depression
Primary Drug/Intervention
Magnetic Seizure Therapy (MST)
Primary Dosage
N/A
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Compelted
Investigator
Lisanby
Sample Size
75
Duration of Study Period for Each Subject
32 weeks
Outcome Measurements
HRSD, IDS-C, IDS-SR, GAF, CGI-I, YMRS, Columbia Univ. ECT side Effects Scale
Results
N/A
Publication
N/A
Link
N/A
PI Name
Sarah Lisanby
Degree
MD
Center
Research Foundation for Mental Hygiene, Inc.
Institution
New York Psychiatric Institute Division
Address
1051 Riverside Drive, Unit #126
City or Town
New York
State or Province
NY
Zip or Postal Code
10032
Country
USA
Email Address
slisanby@columbia.edu